Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Akso Health Group before investing.
In this article, we go over a few key elements for understanding Akso Health Group’s stock price such as:
- Akso Health Group’s current stock price and volume
- Why Akso Health Group’s stock price changed recently
- Upgrades and downgrades for AHG from analysts
- AHG’s stock price momentum as measured by its relative strength
About Akso Health Group (AHG)
Before we jump into Akso Health Group’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.
Akso Health Group, together with its subsidiaries, operates a social e-commerce mobile platform in the People’s Republic of China. It operates Xiaobai Maimai App, a social e-commerce mobile platform that offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment, housewares, home appliances, and cost-saving promotions at petrol gas stations. The company also sells medical devices, such as defibrillators and anesthesia laryngoscopes. In addition, it provides health treatment, consultancy support, and marketing promotion services, as well as trading and technological promotion services and import and export. The company was formerly known as Xiaobai Maimai Inc. and changed its name to Akso Health Group in December 2021. Akso Health Group was founded in 2014 and is headquartered in Qingdao, China.
Want to learn more about Akso Health Group’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Akso Health Group.
What Caused Akso Health Group Stock’s Price to Rise?
Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?
When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of October 01, 2026, there were analysts who downgraded Akso Health Group’s stock and analysts who upgraded over the last month.
Additionally, you'll want to evaluate Akso Health Group’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Akso Health Group’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.
Akso Health Group’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.
Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.
Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Akso Health Group (AHG) by visiting AAII Stock Evaluator.
Relative Price Strength of Akso Health Group
Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.
For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.
As of October 01, 2026, Akso Health Group has a weighted four-quarter relative price strength of -12.00%, which translates to a Momentum Score of 24 and is considered to be Weak.
Want to learn more about how Akso Health Group is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.
Akso Health Group Stock Price: Bottom Line
As of October 1, 2026, Akso Health Group’s stock price is $1.020, which is up 13.33% from its previous closing price.
AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Akso Health Group stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.
Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.
Included With AAII Platinum
at only 6.9%
Gain Since Inception. Data as of 12/31/2024.
769.3% Stock Superstars Portfolio Total Return Since Inception
U.S. Index ETF (IYY)
SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.
FREE REPORT
BECOME A MEMBER FOR ONLY $2
Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.